S. Harari, S. Nathan, J. Behr, W. Wuyts, K. Kirchgaessler, M. Bengus, F. Gilberg, A. Wells
{"title":"西地那非联合吡非尼酮治疗晚期特发性肺纤维化(IPF)和肺动脉高压(PH)风险:一项应答分析的结果","authors":"S. Harari, S. Nathan, J. Behr, W. Wuyts, K. Kirchgaessler, M. Bengus, F. Gilberg, A. Wells","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2434","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":131426,"journal":{"name":"B22. EMERGING MANAGEMENT OF FIBROTIC ILDs","volume":"30 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sildenafil Added to Pirfenidone in Patients with Advanced Idiopathic Pulmonary Fibrosis (IPF) and Risk of Pulmonary Hypertension (PH): Results of a Responder Analysis\",\"authors\":\"S. Harari, S. Nathan, J. Behr, W. Wuyts, K. Kirchgaessler, M. Bengus, F. Gilberg, A. Wells\",\"doi\":\"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2434\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":131426,\"journal\":{\"name\":\"B22. EMERGING MANAGEMENT OF FIBROTIC ILDs\",\"volume\":\"30 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"B22. EMERGING MANAGEMENT OF FIBROTIC ILDs\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2434\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"B22. EMERGING MANAGEMENT OF FIBROTIC ILDs","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2434","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Sildenafil Added to Pirfenidone in Patients with Advanced Idiopathic Pulmonary Fibrosis (IPF) and Risk of Pulmonary Hypertension (PH): Results of a Responder Analysis